A novel method for the rapid and prospective identification of Beijing Mycobacterium tuberculosis strains by high-resolution melting analysis  by Alonso, M. et al.
A novel method for the rapid and prospective identiﬁcation of Beijing
Mycobacterium tuberculosis strains by high-resolution melting analysis
M. Alonso1,2,*, Y. Navarro1,*, F. Barletta3, M. Martı´nez Lirola4,, E. Gotuzzo3, E. Bouza1,2 and D. Garcı´a de Viedma1,2
1) Servicio de Microbiologı´a Clı´nica y Enfermedades Infecciosas, Hospital General Universitario Gregorı`o Maran˜o´n, Madrid, Spain, 2) CIBER Enfermedades
Respiratorias (CIBERES), Spain, 3) Universidad Peruana Cayetano Heredia, Lima, Peru´ and 4) Complejo Hospitalario Torreca´rdenas, Almerı´a, Spain
Abstract
Genotypic analysis of Mycobacterium tuberculosis (MTB) has enabled the deﬁnition of several lineages. The Beijing family, which is consid-
ered highly virulent and transmissible, has been associated with resistance in certain settings and involved in severe outbreaks, making it
one of the most closely-monitored lineages. Therefore, rapid prospective identiﬁcation of Beijing MTB strains could be relevant. In the
present study, we evaluate a real-time PCR followed by high-resolution melting (HRM) based on the identiﬁcation of a single nucleotide
polymorphism (SNP) in the Rv2629 gene which deﬁnes Beijing lineage (A191C for Beijing genotype and A191A for non-Beijing geno-
type). This combined methodology efﬁciently differentiated Beijing and non-Beijing strains in 100% of the isolates from a collection of
reference strains without requiring speciﬁc DNA probes. Additionally, HRM was able to assign a Beijing/non-Beijing genotype in 90.9%
of the respiratory specimens assayed. Its applicability was tested on a Peruvian sample of circulating MTB strains, in which it identiﬁed
10.7% as belonging to the Beijing genotype; this proportion reached 20% in the North Lima area. HRM analysis of the A191C SNP is a
rapid, reliable, and sensitive method for the efﬁcient prospective survey of high-risk Beijing MTB strains, even in developing settings
where MTB culture is often not available.
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Introduction
The application of genotyping tools to the characterization
of Mycobacterium tuberculosis (MTB) has made it possible to
identify different lineages and sublineages, deﬁne their geo-
graphical distribution, and evaluate their infective features
both in vitro and in vivo [1–3].
The phenomenon of immigration has led to the importation
of highly infective and/or resistant strains that are prevalent in
some countries of origin, thus triggering the emergence of
MTB lineages in settings where they were previously unusual
[4,5].
One of the most thoroughly studied and closely monitored
MTB genotypic families is the Beijing lineage, which is preva-
lent in different geographic areas and disseminates easily. The
worldwide distribution of this lineage has been well docu-
mented [6,7]. It is highly prevalent in East Asia and Eastern
Europe, whereas, in Western Europe, it is less represented,
although a slight increase in its prevalence associated with
immigration has been observed over time [4,7].
The Beijing lineage has been associated with drug-resistant
phenotypes in some areas [4,8], and it has been involved in
severe outbreaks [9,10]. Furthermore, infection models have
revealed its infectiveness to be higher than that of other
MTB families [11,12]. Beijing strains have the ability to elude
the innate immune response [13,14], and this characteristic
could play a role in its infective advantage [15,16]. This family
appears better adapted to cause and spread tuberculosis
(TB) in humans than other MTB lineages; therefore, speciﬁc
diagnostic tools must be developed to rapidly identify cases
infected by Beijing strains.
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IS6110-restriction fragment length polymorphism (IS6110-
RFLP) [6,17] and Spoligotyping [18,19] are two genotyping
methods that have been applied to identify Beijing strains
based on their speciﬁc banding or hybridization patterns. An
intact open reading frame in the pks15/1 gene [20] and the
absence of the RDregion [21] were also proposed as useful
markers for identifying Beijing strains.
In the present study, we present a new real-time PCR
followed by high-resolution melting (HRM) analysis to
detect MTB Beijing strains. This approach is based on iden-
tiﬁcation of A191C, a novel single nucleotide polymorphism
(SNP) in the Rv2629 gene that has recently been described
as a marker for the Beijing lineage [22–24]. This method
was evaluated using cultured reference isolates, respiratory
specimens, and a sample of circulating MTB strains from
Peru.
Materials and Methods
Bacterial isolates and clinical samples
Thirty-two MTB strains (18 representatives of the Beijing
genotype and 14 representatives of the non-Beijing genotype,
according to their spoligotypes) were grown on Lowenstein–
Jensen slants (Becton Dickinson, Sparks, MD, USA) and used
as controls. These strains were selected from a collection of
2391 MTB strains genotyped in two population-based studies
run in Madrid and Almeria (south-east Spain) during the per-
iod 2002–2007. The non-Beijing pks15/1+ strains were
selected from a previous study [25].
Eighty-four MTB strains were selected from a prospective
cohort of 145 isolates from ﬁve areas in Peru (San Martin,
Chanchamayo, North Lima, Ica and Arequipa) between
December 2008 and March 2009.
Forty-four smear-positive clinical respiratory samples,
which had been culture-positive for MTB, with high (10–
90 bacilli/F), intermediate (1–9 bacilli/F) and low bacterial
loads (1–9 bacilli/10F) based on the number of acid-fast
bacilli observed [26], were taken from our collection. The
specimens had been decontaminated with the N-acetyl-
L-cysteine NaOH method [27] and frozen at )70C until
use.
As speciﬁcity controls, we used puriﬁed DNA from six
mycobacterial species (Mycobacterium bovis, Mycobacterium
avium, Mycobacterium kansasii, Mycobacterium gordonae,
Mycobacterium fortuitum and Mycobacterium chelonae) and eight
nonmycobacterial species (Streptococcus pneumoniae, Staphylo-
coccus aureus, Enterococcus faecalis, Escherichia coli, Pseudomonas
aeruginosa, Nocardia asteroides, Haemophilus inﬂuenzae and
Klebsiella pneumoniae).
Real-time PCR and HRM analysis
Real-time PCR ampliﬁcation was carried out with the ther-
mal cycler LightCycler 2.0 (Roche Diagnostics, Mannheim,
Germany) using primers described elsewhere [22]. Brieﬂy,
DNA was extracted by a column-based puriﬁcation method
(QIAamp DNA Mini Kit protocol; Qiagen, Courtaboeuf,
France) from 1 mL of the sample in accordance with
the manufacturer’s instructions and eluted in 45 lL of buffer
AE.
2 microliters of puriﬁed DNA was added to a reaction mix-
ture containing 2 lL of LightCycler FastStart DNA Master
HybProbe (Roche Diagnostics), 0.5 lM of each primer, 3 mM
MgCl2 and 1 lL of LightCyler 480 ResoLight Dye (Roche
Diagnostics). The ﬁnal reaction volume was 20 lL. Cycling
conditions were one cycle at 95C for 7 min and 45 cycles at
95C for 15 s, 64C for 30 s, and 72C for 15 s. After ampliﬁ-
cation, the samples were incubated at 95C for 1 min and then
at 40C for 1 min. Melting curve proﬁles were generated by
increasing the temperature from 65C to 95C at a rate of
0.05C/s, and ﬂuorescence was continuously acquired. HRM
analysis was performed using the software LightCycler
480 SW 1.5 (Roche Diagnostics). Normalized melting curves
showed the ﬂuorescence signal against the temperature,
and derivative plots showed the melting temperature (Tm)
peaks.
Heteroduplex analysis
Heteroduplexes were obtained by combining the DNA from
the specimens with DNA from reference Beijing and non-
Beijing strains. Heteroduplexes were analyzed using two
different approaches: (i) a complete PCR-HRM analysis by
co-amplifying problem DNA and reference DNA in equiva-
lent amounts based on the crossing points observed in the
ampliﬁcation of the sample in analysis or (ii) by mixing the
PCR products from the tested sample and reference Beijing
and non-Beijing amplicons to perform an HRM analysis
without a new PCR.
Genotypic characterization of strains
Spoligotyping was performed in accordance with the manu-
facturer’s instructions (Isogen, De Meern, the Netherlands).
The Beijing genotype (deletion of spacers 1–34) designation
was assigned according to the SPOLDB4 database [28].
Results
Real-time PCR and HRM analysis in control strains
The Rv2629 gene was analyzed in 32 M. tuberculosis strains
(18 Beijing and 14 non-Beijing representatives, including the
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reference strain H37Rv) to determine the presence or
absence of the A191C SNP. The normalized melting curves
after the HRM analysis distributed the strains into two inde-
pendent groups (Fig. 1a). The presence of A191C increased
the thermodynamic stability of the amplicon, with the result
that all amplicons from strains belonging to the Beijing lineage
showed a higher melting temperature (Tm) than those belong-
ing to non-Beijing strains. Further analysis of the Tm values
for the amplicons showed higher values for the Beijing strains
(92.4 ± 0.02C) than for the non-Beijing strains (91.9 ±
0.03C) (Fig. 1b). The difference in temperature between the
melting peaks was 0.5 ± 0.02C. Multiple independent analy-
ses with Beijing and non-Beijing strains were performed, and
the range of differences in Tm was 0.45–0.6C.
Once we had observed that the A191C SNP found in
Beijing strains was clearly identiﬁed by HRM analysis, we
explored the exclusiveness of this marker by analyzing a
selection of MTB strains belonging to lineages sharing genetic
markers (intact pks15/1) with the Beijing family. Twenty-ﬁve
non-Beijing MTB strains (13 belonging to the EAI lineage and
12 to the CAS lineage) were analyzed, and none showed a
melting proﬁle corresponding to A191C.
Beijing strain screening by HRM in a sample of Peruvian
strains
With the aim of evaluating the applicability and efﬁciency of
HRM screening, 62 MTB isolates from ﬁve regions in Peru
were analyzed. In 58 (93.5%), a melting pattern correspond-
ing to a non-Beijing genotype was observed and, in the
remaining four (6.5%), a proﬁle consistent with the Beijing
genotype was obtained. Three of the four Beijing strains
identiﬁed corresponded to North Lima. Twenty-two addi-
tional isolates from this area were included in the analysis
and a further ﬁve Beijing strains were identiﬁed. Overall, nine
of 84 (10.7%) of the isolates analyzed corresponded to the
Beijing genotype and, in North Lima, eight of 40 (20%) iso-
lates were of the Beijing genotype. Five of these eight cases
(62.5%) were resistant to at least one drug (including strep-
tomycin) and, among them, three were multidrug-resistant.
All the strains were analyzed by spoligotyping, which
conﬁrmed that the nine Beijing candidates were true repre-
sentatives of this lineage, whereas the remaining isolates
corresponded to non-Beijing genotypes.
Real-time PCR and HRM analysis in clinical samples
The second step in our analysis was to evaluate the efﬁ-
ciency of HRM screening of Beijing strains directly on respi-
ratory samples. Before applying the method to clinical
specimens, we considered the potential interferences that
could occur in the analysis as a result of the presence of
microorganisms other than mycobacteria.
To determine the speciﬁcity of the assay in the presence
of other bacterial DNA, we tested DNA puriﬁed from
cultures of six mycobacterial species and eight non-mycobac-
terial species. The only species showing a melting pattern
similar to that of the MTB isolates was M. bovis, with Tm
values corresponding to a non-Beijing genotype. The melting
proﬁles of the remaining species were markedly different
from those of MTB (11 species), or no ampliﬁcation signal
was detected (three species).
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FIG. 1. High-resolution melting plots for the A191C mutation in the Rv2629 gene. (a) Normalized melting curves of the non-Beijing and Beijing
proﬁles for the 32 cultured Mycobacterium tuberculosis control strains. (b) Derivative melting plot showing melting temperature peaks of non-Beij-
ing (red) and Beijing (blue) genotypes. All reactions were performed in triplicate.
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To evaluate the sensitivity of the HRM analysis, we ana-
lyzed 44 smear-positive clinical respiratory samples with dif-
ferent bacterial loads.
Clinical samples with a high bacterial load
Eighteen sputum samples with a high bacterial load were ana-
lyzed. They all led to ampliﬁcation and allowed HRM analysis
to be performed. Their normalized melting curves were
identical to those of the control strains and all but one were
of the non-Beijing genotype (Fig. 2). The Beijing isolate was
resistant to isoniazid and corresponded to a 27-year-old
Russian man who was HIV-positive and an intravenous drug
user. He had been imprisoned in his country of origin and
was diagnosed with TB 3 months after arrival. The cultures
obtained from all the specimens were analyzed by spoligotyp-
ing, and the genotypes obtained were consistent with the
HRM results.
Clinical samples with a low/intermediate bacterial load
Twenty-six sputum samples with a low/intermediate bacterial
load were analyzed by PCR-HRM and 19 (73.1%) showed
denaturation curves identical to those of the non-Beijing
reference. The remaining seven samples showed aberrant
melting curves that resembled neither the Beijing nor the
non-Beijing proﬁles and showed Tm values that were mark-
edly different from those of the reference strains (Fig. 3).
To resolve the limitations in the analysis of some of the
specimens with a low/intermediate bacterial load, we
designed an indirect second-line assay for cases in which no
deﬁnitive result could be obtained from the direct HRM
assay. This indirect assay was based on the identiﬁcation of
heteroduplexes when DNA from a Beijing strain was com-
bined with DNA from a reference non-Beijing strain and vice
versa. The denaturation behaviour of these heteroduplexes
was intermediate between that of the Beijing and non-Beijing
representatives (Fig. 4).
For the heteroduplex assay, we developed two different
approaches: (i) adding non-Beijing (H37Rv) or Beijing DNA
at the beginning of the reaction mixture to be co-ampliﬁed
with the problem sample and (ii) combining the ampliﬁcation
product of the problem sample with reference Beijing/non-
Beijing amplicons before the HRM analysis.
Six of the nonanalyzable sputa were analyzed using hetero-
duplex induction, which proved effective, both in co-ampliﬁ-
cation or mixing amplicons. In 50% of the cases, this
approach provided us with a result: all the genotypes were
non-Beijing (Fig. 5).
Discussion
The speciﬁc features of the Beijing MTB strains (i.e. associa-
tion with resistance in certain settings, involvement in severe
outbreaks, higher infectivity and higher transmissibility)
[6,7,12] highlight the need for diagnostic strategies based on
rapid identiﬁcation.
Different approaches have been applied. A set of IS6110-
RFLP patterns has been proposed to identify Beijing strains
[6,17], although this does not ensure that all the Beijing
strains are identiﬁed. Indeed, when we applied this set and
the recommended analysis conditions to the 27 Beijing iso-
lates identiﬁed in two population-based molecular studies in
Spain, we observed that only nine (33%) of them had been
identiﬁed as representatives of the Beijing family (data not
shown). Spoligotyping [18,19] is a highly speciﬁc method
for the designation of the Beijing genotype, although it is
time-consuming and is suitable for retrospective/descriptive
studies, but is not adapted to a prospective surveillance pro-
gramme, which is our aim, because it requires a high number
of isolates (N: 45) to be analyzed in each assay. Mycobac-
terial interspersed repetitive-unit-variable-number tandem-
repeat typing, a novel PCR-based typing method for MTB,
has been proposed as a rapid alternative to IS6110-RFLP as
a result of its high correlation with it [29]. However, no spe-
ciﬁc patterns have been proposed as markers to successfully
identify Beijing strains [30,31]. Recently, an intact open
reading frame in the pks15/1 gene [20] was proposed as a
speciﬁc marker for the Beijing lineage, although this was
later identiﬁed in other non-Beijing lineages [25,32]. The
most efﬁcient marker for identiﬁcation of the Beijing geno-
type could be the RD105 deletion [21], and it only requires
speciﬁc PCR and electrophoretic analysis, which makes this
option a good alternative for laboratories lacking advanced
equipment.
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FIG. 2. Normalized melting curves for clinical samples with a high
bacterial load. High-resolution melting plot for 18 smear-positive
clinical samples and Beijing (blue) and non-Beijing (red) reference
strains. All reactions were performed in triplicate.
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New SNP markers in the Rv0927c and Rv2629 genes have
recently been proposed for the Beijing lineage. Jiang et al.
[33,34] described two genetic features in the Rv0927c gene,
the deletion of the serine codon 141 and the mutation
G127A, which were unique to Beijing strains. The SNP in
the Rv2629 gene corresponds to the mutation A191C, which
Wang et al. [35] initially considered to be associated with
resistance to rifampicin in MTB. However, several studies
[22–24] have been unable to demonstrate a correlation
between this SNP and resistance, although they did ﬁnd that
the SNP was really a genetic marker for the Beijing geno-
type.
Recently, a pyrosequencing-based method has been
applied for the identiﬁcation of Beijing isolates, analyzing the
two genetic markers in the Rv0927c gene, and good results
were obtained [36]. However, pyrosequencing devices are
rather expensive equipments, which means that, currently,
they are restricted only to ﬁrst-line laboratories or reference
centres and, unfortunately, they are still absent from most
of the standard microbiology laboratories. We aimed to
develop another alternative molecular strategy focused on
the identiﬁcation of A191C by HRM. To ensure the applica-
tion of our proposal, our method is performed on real-time
PCR devices, which are much accessible for the average
laboratory. HRM analysis has been reported to be a useful
tool for human and bacterial genotyping [37,38]. PCR prod-
ucts are analyzed using saturating DNA dyes instead of
labelled probes, thus reducing costs. This method detects
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FIG. 3. Normalized melting curves for clinical samples with a low/intermediate bacterial load. (a) Melting plot for 19 smear-positive clinical sam-
ples and Beijing and non-Beijing reference strains. (b) Aberrant normalized melting curves of representative samples. In some cases, no ﬂuores-
cent signal was detected, as shown in the representative sample in the ﬁgure. In the inner square, the melting temperature peaks for the same
strains are shown. Non-Beijing (red) and Beijing proﬁles (blue) are indicated. All reactions were performed in triplicate.
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FIG. 4. Heteroduplex induction. (a) Normalized melting curves of a non-Beijing strain, a Beijing strain, and an intermediate thermodynamic prod-
uct, the heteroduplex. (b) Derivative melting plot. The heteroduplex product showed an intermediate melting temperature peak. Non-Beijing
(red), Beijing (blue) and heteroduplex (green) proﬁles are shown. All reactions were performed in triplicate.
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genetic variations in PCR products, such as mutations, SNPs
and methylations [39,40], and has recently been applied for
the rapid identiﬁcation of different bacterial species [38,41],
determination of allelic variants of Bacillus anthracis [42],
deﬁnition of inﬂuenza A subtypes [43], detection and quanti-
ﬁcation of human papillomavirus [44], and detection of
quinolone resistance in Salmonella enterica [45]. HRM tech-
nology has also been speciﬁcally applied in mycobacteriology,
although it has been limited to scanning of mutations in rpob
aiming to identify multidrug-resistant strains [46].
To extend the applicability of HRM in the ﬁeld of myco-
bacteriology, we designed an application to rapidly identify
Beijing strains. We ﬁrst analyzed the thermodynamic stability
of the PCR products from a selection of cultured MTB
strains, including Beijing and non-Beijing representatives char-
acterized by spoligotyping and analysis of pks15/1 and of
RD105. All the Beijing representatives showed an increased
stability of the Rv2629 amplicon to be denatured as a result
of the presence of A191C. The Beijing and non-Beijing iso-
lates were distributed in two clearly different groups accord-
ing to their denaturing patterns. In all the assays, the Tm
value for the Beijing and non-Beijing isolates was in the range
0.45–0.6C.
Genetic markers considered to be speciﬁc for Beijing
were later found in other non-Beijing lineages. Such was the
case of pks15-1, which was initially considered to be intact
only in Beijing isolates [20,21], but was later identiﬁed in
non-Beijing lineages (EIA and CAS) [25,32]. We evaluated a
selection of non-Beijing strains belonging to these lineages in
our PCR-HRM assay and they all behaved as non-Beijing iso-
lates, thus conﬁrming the exclusiveness of A191C for the
Beijing genotype.
Slight inter-assay differences in the absolute Tm values
were observed; therefore, both Beijing and non-Beijing intra-
assay control strains should be included. Furthermore, subtle
deviations in the Tm values were recorded, depending on the
DNA extraction method applied; DNAs puriﬁed with col-
umn-based methods revealed slightly lower Tm values than
DNAs puriﬁed with noncommercial systems (cetyl trimethyl
ammonium bromide-chloroform/isoamyl alcohol-isopropanol
procedures). The same DNA extraction procedure should
be applied for all the samples analyzed in the same PCR-
HRM run.
The applicability of HRM in determining the representa-
tiveness of the Beijing family in samples of circulating strains
was assessed in a selection of 84 isolates from different
regions in Peru. A new route of importation of Beijing
strains from South America to Europe has been described
[47,48] and, in our setting, most of the immigrant cases
infected by Beijing strains correspond to Peruvians and Ecu-
adorians. Some epidemiological studies have shown that the
prevalence of the Beijing genotype in South America was
approximately 1.6% [49,50], although studies ascertaining the
prevalence of Beijing strains in this area are scarce and the
values vary in the range 0–5.9% in Peru [49], Argentina [51],
Paraguay [52] and Venezuela [53].
The thermodynamic behaviour of the Peruvian isolates
analyzed matched the Beijing proﬁle in 10.7% of all the cases
analyzed. These values reached 20% in the North Lima area,
which includes all but one of the Beijing isolates from the
ﬁve areas. These ﬁgures are higher than those reported pre-
viously [49]. It would be interesting to perform a more thor-
ough analysis in North Lima, given the high prevalence of
Beijing strains that we report for that region.
Our strategy is one of several that can rapidly identify
Beijing isolates. Single, multiplex and real-time PCR-based
techniques [54–56] have been shown to detect the Beijing
genotype. However, they all focused on cultured isolates and
not clinical specimens. The possibility of identifying Beijing
strains by direct analysis of the bacilli in clinical specimens,
without requiring culture, would allow to extend the survey
of this lineage to countries where MTB is not systematically
cultured and only respiratory samples are expected to be
available for analysis. Therefore, we evaluated the efﬁciency
of our approach with clinical specimens, taking both speciﬁc-
ity and sensitivity into account. With regard to speciﬁcity,
we initially evaluated the potential interferences that could
result from the presence of other respiratory pathogens/col-
onizers in the respiratory sample. No non-MTB ﬂuorescent
signal or denaturing proﬁles were observed for 13 different
non-M. tuberculosis species. M. bovis was the only microor-
ganism to share a pattern with MTB, although this was not a
cause for confusion because it corresponded to the non-Beij-
ing pattern.
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With respect to sensitivity, 44 clinical respiratory samples
with different MTB bacterial loads were analyzed, and we
succeeded in assigning a Beijing/non-Beijing type in a high
percentage (84.1%). It is noteworthy that a result was
obtained in 100% of the specimens with a high bacterial load.
In the samples with a low/intermediate load, we were unable
to assign a genotype in 26.9% of the specimens (these
showed aberrant proﬁles).
In cases not resolved by direct PCR-HRM assay, we
designed an alternative indirect analysis method based on
the detection of heteroduplexes [57] when Beijing and non-
Beijing DNA are combined. This approach was performed in
two different ways. First, we co-ampliﬁed in the same reac-
tion the problem sample with Beijing and non-Beijing refer-
ence DNA. To ﬁx the amount of reference DNA to be
included in the reaction, it is ﬁrst necessary to deﬁne the
amount of DNA present in the extract from the clinical sam-
ple. This data can be inferred from the crossing point of the
sample and, therefore, PCR is necessary before the hetero-
duplex analysis. Second, we combined the ampliﬁcation prod-
uct from the sample with Beijing and non-Beijing reference
amplicons to perform a new HRM analysis without the need
for an additional PCR. Although this format entails a higher
probability of post-PCR laboratory contamination, it is
expected to be applied in only a few specimens with excep-
tionally low bacterial loads in which a result by direct HRM
could not be deﬁnitive.
Indirect analysis by observing heteroduplexes allowed us
to assign a genotype in 50% of the samples with a low/inter-
mediate bacterial load that had not allowed us to obtain a
result with direct PCR-HRM. Both approaches were equally
effective, although a global evaluation of this indirect analysis
showed that the mixture of PCR products was more decisive
and efﬁcient than co-ampliﬁcation of DNAs. In summary,
HRM analysis was able to assign a Beijing/non-Beijing geno-
type in 91% of the clinical specimens analyzed.
The Beijing lineage is causing major concern worldwide.
HRM analysis of the SNP A191C in Rv2629 is a novel, rapid,
and reliable method for genotyping MTB in both cultured iso-
lates and clinical respiratory samples. This approach is highly
efﬁcient for rapid screening of Beijing strains in different popu-
lations. It could enable us to document the representativeness
of the lineage and to extend the survey of its spread to settings
where its detection is not usually performed.
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